Longevity.Technology: Cambrian Biopharma exits stealth with $60m and affiliate IPO

5

 min read

9

Feb

21

Cambrian Biopharma, a distributed development company, exits stealth mode with the announcement that it has raised $60 million in private financing to develop medicines to extend healthy lifespan.

>